BioShares Biotechnology News

BioShares Biotechnology Clinical Trials -- USA Etf  

USD 30.75  0.15  0.49%

Macroaxis does not monitor all media channels or aggregates social signals for BioShares Biotechnology. But even though we do not provide professional-grade financial sentiment analysis on BioShares Biotechnology, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for BioShares Biotechnology. Check also BioShares Biotechnology Hype Analysis, BioShares Biotechnology Correlation and BioShares Biotechnology Performance
  
a day ago at weeklyregister.com         
BioShares Biotechnology Clinical Trials Rises 2.51 percent for Jan 17
news
More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com with their article The Zacks ...
  
  
few days ago at www.thelincolnianonline.com         
Virtus LifeSci Biotech Clinical Trials ETF Declares Annual ...
news
Virtus LifeSci Biotech Clinical Trials ETF announced an annual dividend on Thursday, December 21st, Wall Street Journal reports. Does Bioshares Biotechnology Clinical Have Gas After Even More ... - BZ Weekly Bioshares Biotechnology Clinical on Focus After Report of More ... - Press Telegraph
  
  
over two weeks ago at weeklyregister.com         
BioShares Biotechnology Clinical Trials Declines 0.94 percent for Dec 31
news
Weekly Register - Dec 31, 2017 More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com with their article The Zacks ...
  
  
over three weeks ago at ledgergazette.com         
Virtus LifeSci Biotech Clinical Trials ETF Plans Annual Dividend of 0.30
news
The Ledger Gazette - Dec 22, 2017 Virtus LifeSci Biotech Clinical Trials ETF logo Virtus LifeSci Biotech Clinical Trials ETF declared an annual dividend on Thursday, December 21st, Wall Street Journal reports. Bioshares Biotechnology Clinical on Focus After Report of More ... - Frisco Fastball
  
  
over a month ago at bzweekly.com         
BioShares Biotechnology Clinical Trials Declines 1.778 percent for Dec 14
news
More notable recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com with their article Value Biotech ... BioShares Biotechnology Products Declines 1.04 percent for Dec 14 - Weekly Register
  
  
over a month ago at weeklyhub.com         
BioShares Biotechnology Clinical Trials Rises 1.5468 percent for Dec 8
news
WeeklyHub - Dec 8, 2017 More important recent Virtus LifeSci Biotech Clinical Trls ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com published article titled Best ... BioShares Biotechnology Products Rises 2.0717 percent for Dec 8 - Press Telegraph
  
  
over two months ago at weeklyregister.com         
BioShares Biotechnology Clinical Trials Declines 0.48 percent for Nov 17
news
Weekly Register - Nov 17, 2017 More notable recent Virtus LifeSci Biotech Clinical Trials ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014, also Nasdaq.com with their article Best Sector ... Bioshares Biotechnology Clinical Can39t Be Less Risky. Short ... - KL Daily
  
  
over two months ago at finnewsdaily.com         
BioShares Biotechnology Products Rises 0.3 percent for Nov 1
news
... ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Products ETF on December 17, 2014, also Marketwatch.
  
  
over two months ago at weeklyregister.com         
BioShares Biotechnology Products Declines 2.5 percent for Oct 24
news
Weekly Register - Oct 24, 2017 ... Virtus LifeSci Biotech Products ETF news were published by Marketwatch.com which released Virtus LifeSci Biotech Products ETF on December 17, 2014, also Marketwatch.com with their article Virtus LifeSci Biotech Clinical Trials ...
  
  
over three months ago at weeklyhub.com         
Bioshares Biotechnology Clinical Ca not Be More Risky. Short ...
news
More notable recent Virtus LifeSci Biotech Clinical Trials ETF news were published by Benzinga.com which released Life Lessons The Hows And Whos To Play Biotech on October 06, 2017, also Globenewswire. Is Bioshares Biotechnology Clinical a Buy The Stock Reported ... - BZ Weekly
  
  
over three months ago at bzweekly.com         
Is Buying Bioshares Biotechnology Clinical Here Good Idea
news
More important recent Virtus LifeSci Biotech Clinical Trials ETF news were published by Prnewswire.com which released Virtus ETF Solutions Rebrands BioShares ETFs Moves Listings for BBC, BBP to on August 30, 2017, also ...
  
  
over three months ago at weeklyhub.com         
Bioshares Biotechnology Clinical Sellers Increased By 0.19 ...
news
More interesting news about Virtus LifeSci Biotech Clinical Trials ETF were released by Globenewswire.com and their article BioShares Biotechnology ETFs Complete Semi-Annual Rebalance and Recomposition published on June 16, ...
  
  
over three months ago at bzweekly.com         
BioShares Biotechnology Products Declines 0.63 percent for Sep 8
news
published on August 30, 2017, Marketwatch.com published Virtus LifeSci Biotech Clinical Trials ETF on December 16, 2014. BioShares Biotechnology Clinical Trials Rises 0.04 percent for Sep 8 - Press Telegraph
  
  
over three months ago at simplywall.st         
Who Are The Major Shareholders Of Black Birch Capital Acquisition III Corp ...
news
In this analysis, my focus will be on developing a perspective on Black Birch Capital Acquisition III Corp TSXVBBC.
  
  
over three months ago at danvilledaily.com         
Following the Levels for this Stock ETFis BioShares Biotechnology Clinical ...
news
Shares of ETFis BioShares Biotechnology Clinical Trials Fund have recently come under renewed examination. The Relative Strength Index is one of multiple popular technical indicators created by J. Welles Wilder.
  

Latest Stories

Recently Published Macroaxis Headlines
Price Growth (%)  
      Timeline 
1
BioShares Biotechnology Clinical Trials Rises 2.51 percent f...01/17/2018

Pair Trading

BioShares Biotechnology Pair Trading Analysis
Correlation analysis and pair trading evaluation for BioShares Biotechnology and Health Care Select. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas